JP2019533425A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533425A5 JP2019533425A5 JP2019501482A JP2019501482A JP2019533425A5 JP 2019533425 A5 JP2019533425 A5 JP 2019533425A5 JP 2019501482 A JP2019501482 A JP 2019501482A JP 2019501482 A JP2019501482 A JP 2019501482A JP 2019533425 A5 JP2019533425 A5 JP 2019533425A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- sequence identity
- sequence
- functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 claims 18
- 102000036639 antigens Human genes 0.000 claims 18
- 108091007433 antigens Proteins 0.000 claims 18
- 239000012634 fragment Substances 0.000 claims 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 208000001455 Zika Virus Infection Diseases 0.000 claims 5
- 208000035332 Zika virus disease Diseases 0.000 claims 5
- 208000020329 Zika virus infectious disease Diseases 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 4
- 208000001490 Dengue Diseases 0.000 claims 2
- 206010012310 Dengue fever Diseases 0.000 claims 2
- 241000907316 Zika virus Species 0.000 claims 2
- 208000025729 dengue disease Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 101710091045 Envelope protein Proteins 0.000 claims 1
- 102000009109 Fc receptors Human genes 0.000 claims 1
- 108010087819 Fc receptors Proteins 0.000 claims 1
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims 1
- 101710188315 Protein X Proteins 0.000 claims 1
- 102100021696 Syncytin-1 Human genes 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims 1
- 230000034217 membrane fusion Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023019144A JP2023062036A (ja) | 2016-07-13 | 2023-02-10 | ジカウイルスエピトープに特異的に結合する新規抗体及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2016/066684 WO2018010789A1 (en) | 2016-07-13 | 2016-07-13 | Novel antibodies specifically binding to zika virus epitopes and uses thereof |
| EPPCT/EP2016/066684 | 2016-07-13 | ||
| PCT/EP2017/067581 WO2018011283A1 (en) | 2016-07-13 | 2017-07-12 | Novel antibodies specifically binding to zika virus epitopes and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023019144A Division JP2023062036A (ja) | 2016-07-13 | 2023-02-10 | ジカウイルスエピトープに特異的に結合する新規抗体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019533425A JP2019533425A (ja) | 2019-11-21 |
| JP2019533425A5 true JP2019533425A5 (enExample) | 2020-07-27 |
| JP7252888B2 JP7252888B2 (ja) | 2023-04-05 |
Family
ID=56413654
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501482A Active JP7252888B2 (ja) | 2016-07-13 | 2017-07-12 | ジカウイルスエピトープに特異的に結合する新規抗体及びその使用 |
| JP2023019144A Pending JP2023062036A (ja) | 2016-07-13 | 2023-02-10 | ジカウイルスエピトープに特異的に結合する新規抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023019144A Pending JP2023062036A (ja) | 2016-07-13 | 2023-02-10 | ジカウイルスエピトープに特異的に結合する新規抗体及びその使用 |
Country Status (31)
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6998935B2 (ja) | 2016-07-13 | 2022-01-18 | エボニック オペレーションズ ゲーエムベーハー | 溶解された脂質含有バイオマスから脂質を分離する方法 |
| AU2017343778A1 (en) | 2016-10-13 | 2019-05-02 | Massachusetts Institute Of Technology | Antibodies that bind Zika virus envelope protein and uses thereof |
| WO2019042555A1 (en) | 2017-08-31 | 2019-03-07 | Humabs Biomed Sa | MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF |
| EP3527664A1 (en) | 2018-02-15 | 2019-08-21 | Evonik Degussa GmbH | Method of isolating lipids from a lipids containing biomass |
| JP2019152666A (ja) * | 2018-03-02 | 2019-09-12 | 富士レビオ株式会社 | ジカウイルスを検出する方法及びキット |
| US11884718B2 (en) | 2018-04-24 | 2024-01-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination |
| RU2760575C1 (ru) | 2018-05-15 | 2021-11-29 | Эвоник Оперейшнс Гмбх | Способ выделения липидов из содержащей липиды биомассы с помощью гидрофобного диоксида кремния |
| BR112020023222A2 (pt) | 2018-05-15 | 2021-03-23 | Evonik Operations Gmbh | método de isolamento de lipídios a partir de uma biomassa contendo lipídios lisados por inversão por emulsão |
| WO2020061159A1 (en) * | 2018-09-20 | 2020-03-26 | Vanderbilt University | Human antibodies to zika virus |
| WO2020078568A1 (en) * | 2018-10-19 | 2020-04-23 | Humabs Biomed Sa | Antibodies and methods for treatment of lyssavirus infection |
| BR112021008217A2 (pt) * | 2018-10-31 | 2021-08-17 | Icahn School Of Medicine At Mount Sinai | anticorpos humanos que têm como alvo vírus zika ns1, polipeptídeos ns1 e seus usos |
| WO2020106358A1 (en) | 2018-11-20 | 2020-05-28 | Takeda Vaccines, Inc. | Novel anti-zika virus antibodies and uses thereof |
| WO2020245663A1 (en) * | 2019-06-01 | 2020-12-10 | Institut Pasteur | Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection |
| WO2021050989A1 (en) * | 2019-09-13 | 2021-03-18 | Duke University | Zika antibodies and their use |
| MX2022005498A (es) * | 2019-11-07 | 2022-08-11 | Inst Microbiology Cas | Vacuna del zika/dengue y aplicación de la misma. |
| EP4061422A4 (en) * | 2019-11-19 | 2024-05-08 | Vanderbilt University | HUMAN ANTIBODIES NEUTRALIZING ZIKA VIRUS AND METHODS OF USE THEREOF |
| CN111100201B (zh) * | 2019-12-31 | 2021-09-28 | 武汉班科生物技术股份有限公司 | 针对寨卡病毒囊膜蛋白的鼠源单克隆抗体 |
| CN111138534B (zh) * | 2019-12-31 | 2021-09-28 | 武汉班科生物技术股份有限公司 | 寨卡病毒囊膜蛋白的鼠源单克隆抗体 |
| JP7471555B2 (ja) * | 2020-02-20 | 2024-04-22 | 国立感染症研究所長 | フラビウイルス交差中和抗体及び医薬組成物 |
| WO2021236225A1 (en) | 2020-05-20 | 2021-11-25 | Takeda Vaccines, Inc. | Method for detection of zika virus specific antibodies |
| EP4153222A1 (en) | 2020-05-20 | 2023-03-29 | Takeda Vaccines, Inc. | Method for detection of zika virus specific antibodies |
| US20230204567A1 (en) | 2020-05-20 | 2023-06-29 | Takeda Vaccines, Inc. | Method for determining the potency of antigens |
| CN115697392A (zh) * | 2020-06-28 | 2023-02-03 | 神州细胞工程有限公司 | 一种降低病毒ade效应的方法 |
| WO2022212858A2 (en) * | 2021-04-01 | 2022-10-06 | A2 Biotherapeutics, Inc. | Polypeptides targeting hla-a*11 and methods of use thereof |
| CN112921124B (zh) * | 2021-04-08 | 2021-09-28 | 广东创晟控股集团有限公司 | 一种快速检测病毒的试剂盒 |
| WO2024211789A1 (en) * | 2023-04-07 | 2024-10-10 | Fred Hutchinson Cancer Center | Cross-flavivirus binding domains and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3766162A (en) | 1971-08-24 | 1973-10-16 | Hoffmann La Roche | Barbituric acid antigens and antibodies specific therefor |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4233402A (en) | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US4831175A (en) | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
| US5595721A (en) | 1993-09-16 | 1997-01-21 | Coulter Pharmaceutical, Inc. | Radioimmunotherapy of lymphoma using anti-CD20 |
| MY133346A (en) | 1999-03-01 | 2007-11-30 | Biogen Inc | Kit for radiolabeling ligands with yttrium-90 |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| AU2003263853A1 (en) * | 2002-08-16 | 2004-03-03 | Board Of Regents The University Of Texas System | Compositions and methods related to flavivirus envelope protein domain iii antigens |
| AU2004215125B2 (en) | 2003-02-26 | 2011-01-06 | Institute For Research In Biomedicine | Monoclonal antibody production by EBV transformation of B cells |
| WO2005000898A2 (en) * | 2003-06-27 | 2005-01-06 | Biogen Idec Ma Inc. | Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| BRPI0811857A2 (pt) * | 2007-05-14 | 2014-10-21 | Biogen Idec Inc | Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados. |
| ES2525346T3 (es) | 2008-10-22 | 2014-12-22 | Institute For Research In Biomedicine | Métodos para producir anticuerpos a partir de células plasmáticas |
| EP4292657A3 (en) * | 2013-03-15 | 2024-03-20 | Dana Farber Cancer Institute, Inc. | Flavivirus neutralizing antibodies and methods of use thereof |
| KR20180127397A (ko) | 2016-03-11 | 2018-11-28 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 생약독화된 지카 바이러스 백신 |
| WO2017181098A2 (en) * | 2016-04-15 | 2017-10-19 | Visterra, Inc. | Antibody molecules to zika virus and uses thereof |
| TW201815821A (zh) | 2016-07-18 | 2018-05-01 | 美商再生元醫藥公司 | 抗茲卡病毒抗體及使用方法 |
| EP3658557B1 (en) | 2017-07-28 | 2024-06-05 | Takeda Pharmaceutical Company Limited | Tyk2 inhibitors and uses thereof |
-
2016
- 2016-07-13 WO PCT/EP2016/066684 patent/WO2018010789A1/en not_active Ceased
-
2017
- 2017-07-12 CR CR20190066A patent/CR20190066A/es unknown
- 2017-07-12 JP JP2019501482A patent/JP7252888B2/ja active Active
- 2017-07-12 EP EP23191207.2A patent/EP4342911A1/en not_active Withdrawn
- 2017-07-12 DK DK17742985.9T patent/DK3484915T5/da active
- 2017-07-12 SG SG11201809879WA patent/SG11201809879WA/en unknown
- 2017-07-12 HR HRP20231196TT patent/HRP20231196T1/hr unknown
- 2017-07-12 AU AU2017297757A patent/AU2017297757B2/en not_active Expired - Fee Related
- 2017-07-12 US US16/317,533 patent/US11117954B2/en not_active Expired - Fee Related
- 2017-07-12 CN CN202211721078.3A patent/CN116199775A/zh active Pending
- 2017-07-12 IL IL262710A patent/IL262710B2/en unknown
- 2017-07-12 PH PH1/2018/502348A patent/PH12018502348B1/en unknown
- 2017-07-12 UA UAA201901101A patent/UA126381C2/uk unknown
- 2017-07-12 EP EP17742985.9A patent/EP3484915B1/en active Active
- 2017-07-12 KR KR1020197004192A patent/KR102595764B1/ko active Active
- 2017-07-12 SI SI201731420T patent/SI3484915T1/sl unknown
- 2017-07-12 MX MX2019000526A patent/MX2019000526A/es unknown
- 2017-07-12 EA EA201990243A patent/EA201990243A1/ru unknown
- 2017-07-12 BR BR112018074456-5A patent/BR112018074456A2/pt not_active IP Right Cessation
- 2017-07-12 PE PE2019000034A patent/PE20190398A1/es unknown
- 2017-07-12 LT LTEPPCT/EP2017/067581T patent/LT3484915T/lt unknown
- 2017-07-12 CA CA3024374A patent/CA3024374A1/en active Pending
- 2017-07-12 WO PCT/EP2017/067581 patent/WO2018011283A1/en not_active Ceased
- 2017-07-12 MY MYPI2018704108A patent/MY190553A/en unknown
- 2017-07-12 FI FIEP17742985.9T patent/FI3484915T3/fi active
- 2017-07-12 CN CN201780042888.7A patent/CN109563157B/zh active Active
- 2017-07-12 HU HUE17742985A patent/HUE063272T2/hu unknown
- 2017-07-12 ES ES17742985T patent/ES2959883T3/es active Active
- 2017-07-12 PL PL17742985.9T patent/PL3484915T3/pl unknown
-
2018
- 2018-11-07 ZA ZA2018/07467A patent/ZA201807467B/en unknown
-
2019
- 2019-01-08 DO DO2019000006A patent/DOP2019000006A/es unknown
- 2019-01-09 CL CL2019000067A patent/CL2019000067A1/es unknown
- 2019-02-05 CO CONC2019/0001111A patent/CO2019001111A2/es unknown
- 2019-02-07 EC ECSENADI20199170A patent/ECSP19009170A/es unknown
-
2021
- 2021-02-10 DO DO2021000026A patent/DOP2021000026A/es unknown
- 2021-06-01 US US17/335,799 patent/US20210363227A1/en not_active Abandoned
- 2021-06-01 US US17/335,792 patent/US11912757B2/en active Active
- 2021-11-12 CL CL2021002994A patent/CL2021002994A1/es unknown
-
2023
- 2023-02-10 JP JP2023019144A patent/JP2023062036A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533425A5 (enExample) | ||
| JP2018535650A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2020531000A5 (enExample) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| JP2023071956A5 (enExample) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2023085476A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| RU2009129403A (ru) | Антитела, нейтрализующие цитомегаловирус человека, и их применение | |
| JP2018521638A5 (enExample) | ||
| JP2020037555A5 (enExample) | ||
| JP2011528901A5 (enExample) | ||
| JP2019522961A5 (enExample) | ||
| JP2020500538A5 (enExample) | ||
| JP2016503413A5 (enExample) | ||
| JP2010521147A5 (enExample) | ||
| JP2019502712A5 (enExample) | ||
| RU2588467C3 (ru) | Стабильные и растворимые антитела, ингибирующие vegf | |
| JP2017534577A5 (enExample) | ||
| JP2012512641A5 (enExample) | ||
| JP2017534646A5 (enExample) | ||
| JP2020525411A5 (enExample) | ||
| JP2025032102A5 (enExample) | ||
| JP2017534644A5 (enExample) |